Q1 FY27: revenue up 20% but exceptional charge weighs on PAT

Revenue growth above 20%Exceptional itemResults View source PDF Explain this filing

RPSGVENT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹884.25

prior close

₹942.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+2.2% vs market

Business Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO) peers, median of 9sector+0.0%+2.4% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 2.4 pts more than its Business Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-1.5

15m

-1.9

30m

-2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4+0.2+2.2+0.0+2.4

Next day

+0.7+0.2+0.5+0.8-0.1

+0.1+0.4-0.3+0.7-0.6

-1.0+0.7-1.8+0.0-1.1

-2.7+0.1-2.9+0.2-2.9

-2.1+0.7-2.7-0.1-2.0

-2.0+1.2-3.1-0.9-1.0

15d

-6.0+0.7-6.7-1.9-4.1

-5.8-1.2-4.6-2.0-3.8

-1.5-1.1-0.4+5.7-7.2

—————

UpDownMarket · Nifty Microcap 250Sector · Business Process Outsourcing (BPO)/ Knowledge Process Outsourcing (KPO) peers, median of 9Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RPSG Ventures posted Q1 FY27 consolidated revenue from operations of Rs. 3,576.44 crore, up 20.4% YoY from Rs. 2,971.41 crore. Profit after tax was Rs. 253.09 crore versus Rs. 251.09 crore, nearly flat. An exceptional charge of Rs. 71.69 crore from a subsidiary (contract termination and client indemnification) weighed on earnings. Process Outsourcing and Sports segments drove growth. Board approved amalgamation of Woodlands Multispeciality Hospital and incorporated an FMCG subsidiary for the MENA region. Auditor issued an unqualified review.

Likely market impact

Strong topline growth but exceptional charges from a subsidiary dragged PAT. Watch for recovery outcome on the affected subsidiary contracts.